Displaying drugs 51 - 75 of 137 in total
| DrugBank ID | Name CAS Number |
Weight Formula |
Structure | Categories | Therapeutic Indication |
|---|---|---|---|---|---|
| DB00094 |
Urofollitropin
146479-72-3 |
980.1620 C42H65N11O12S2 |
|
Fertility Agents | For treatment of female infertility |
| DB00093 |
Felypressin
56-59-7 |
1040.2190 C46H65N13O11S2 |
|
Renal Agents / Vasoconstrictor Agents | For use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential. |
| DB00092 |
Alefacept
222535-22-0 |
51801.1000 C2306H3594N610O694S26 |
|
Immunomodulatory Agents / Immunosuppressive Agents | As an immunosuppressive drug, Alefacept can be used for treatment of moderate to severe chronic plaque psoriasis |
| DB00091 |
Cyclosporine
59865-13-3 |
1202.6112 C62H111N11O12 |
|
Antirheumatic Agents / Immunomodulatory Agents / Enzyme Inhibitors / Dermatologic Agents / Immunosuppressive Agents / Antifungal Agents | For treatment of transplant rejection, rheumatoid arthritis, severe psoriasis |
| DB00090 |
Laronidase
210589-09-6 |
69899.4000 C3160H4848N898O881S12 |
|
Enzyme Replacement Agents | For the treatment of mucopolysaccharidosis |
| DB00089 |
Capromab
145464-28-4 |
|
Imaging Agents | For diagnosis of prostate cancer and detection of intra-pelvic metastases. | |
| DB00088 |
Alglucerase
37228-64-1 |
55597.4000 C2532H3854N672O711S16 |
|
Enzyme Replacement Agents | For the treatment of Gaucher's disease (deficiency in glucocerebrosidase) |
| DB00087 |
Alemtuzumab
216503-57-0 |
145453.8000 C6468H10066N1732O2005S40 |
|
Antineoplastic Agents | Alemtuzumab (Campath) is a monoclonal antibody therapy used for treatment of B-cell chronic lymphocytic leukemia. |
| DB00086 |
Streptokinase
9002-01-1 |
47286.7000 C2100H3278N566O669S4 |
|
Thrombolytic Agents | For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and ... |
| DB00085 |
Pancrelipase
53608-75-6 |
131125.6000 C5850H8902N1606O1739S49 |
|
Enzyme Replacement Agents | For treatment of exocrine pancreatic insufficiency in cystic fibrosis (Ultresa™), chronic pancreatitis (Viokace™ in combination with a proton pump ... |
| DB00083 |
Botulinum Toxin Type A
93384-43-1 |
149322.7000 C6760H10447N1743O2010S32 |
|
Anti-Wrinkle Agents / Antidystonic Agents / Neuromuscular Blocking Agents | For the treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia... |
| DB00082 |
Pegvisomant
218620-50-9 |
22129.0000 C990H1532N262O300S7 |
|
Anabolic Agents / Hormone Replacement Agents | Pegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly. |
| DB00081 |
Tositumomab
192391-48-3 |
143859.7000 C6416H9874N1688O1987S44 |
|
Antineoplastic Agents | For treatment of non-Hodgkin's lymphoma (CD20 positive, follicular) |
| DB00080 |
Daptomycin
103060-53-3 |
1620.6706 C72H101N17O26 |
|
Anti-Bacterial Agents | For the treatment of complicated skin and skin structure infections caused by susceptible strains of Gram-positive microorganisms. |
| DB00078 |
Ibritumomab
174722-31-7 |
143375.5000 C6382H9830N1672O1979S54 |
|
Antineoplastic Agents | For treatment of non-Hodgkin's lymphoma |
| DB00076 | Digoxin Immune Fab |
47301.7000 C2085H3223N553O672S16 |
|
Digoxin Antidote | For treatment of digitoxin overdose or digitalis glycoside toxicity. |
| DB00075 |
Muromonab
140608-64-6 |
146189.7000 C6460H9946N1720O2043S56 |
|
Immunomodulatory Agents / Immunosuppressive Agents | For treatment of organ transplant recipients, prevention of organ rejection |
| DB00074 |
Basiliximab
152923-56-3 |
143801.3000 C6378H9844N1698O1997S48 |
|
Immunomodulatory Agents / Immunosuppressive Agents | For prophylactic treatment of kidney transplant rejection |
| DB00073 |
Rituximab
174722-31-7 |
143859.7000 C6416H9874N1688O1987S44 |
|
Antineoplastic Agents | For treatment of CD20-positive non-Hodgkins lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. |
| DB00072 |
Trastuzumab
180288-69-1 |
145531.5000 C6470H10012N1726O2013S42 |
|
Antineoplastic Agents | For treatment of early stage HER2-positive breast cancer, or metastatic breast cancer that substantially overexpress HER2. |
| DB00071 |
Insulin, porcine
9004-14-2 |
5795.6000 C257H387N65O76S6 |
|
Hypoglycemic Agents | For the treatment of type I and II diabetes mellitus. |
| DB00070 |
Hyaluronidase
488712-31-8 |
53870.9000 C2455H3775N617O704S21 |
|
Anesthetic Adjuvants / Permeabilizing Agents | For increase of absorption and distribution of other injected drugs and for rehydration. |
| DB00069 |
Interferon alfacon-1
118390-30-0 |
19343.0000 C860H1353N227O255S9 |
|
Antineoplastic Agents / Immunomodulatory Agents / Antiviral Agents | For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma |
| DB00068 |
Interferon beta-1b
145155-23-3 |
20011.0000 C908H1408N246O253S6 |
|
Immunomodulatory Agents / Antiviral Agents | Interferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease... |
| DB00067 |
Vasopressin
11000-17-2 |
1050.2150 C43H67N15O12S2 |
|
Antidiuretics / Vasoconstrictor Agents / Oxytocics | For the treatment of enuresis, polyuria, diabetes insipidus, polydipsia and oesophageal varices with bleeding |
Displaying drugs 51 - 75 of 137 in total